Your browser doesn't support javascript.
loading
Presence of MET exon 14 skipping and fusion as mechanism of osimertinb resistance in a lung adenocarcinoma with an EGFR exon 19 deletion that responds to combination of capmatinib and osimertinb: A case report.
Xiang, Siqi; Zeng, Liang; Xiang, Mingjun; Zhang, Yongchang.
Affiliation
  • Xiang S; Department of Biochemistry and Immunology, Medical Research Center, Institute of Medicine, Jishou University, Jishou, 416000, China.
  • Zeng L; Department of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, 410013, China.
  • Xiang M; Department of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, 410013, China.
  • Zhang Y; Department of Biochemistry and Immunology, Medical Research Center, Institute of Medicine, Jishou University, Jishou, 416000, China.
Heliyon ; 9(11): e22515, 2023 Nov.
Article in En | MEDLINE | ID: mdl-38074875
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Heliyon Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Heliyon Year: 2023 Document type: Article Affiliation country: Country of publication: